Clinical Report: Addressing Recurrent Weight Gain Following Sleeve Gastrectomy

Overview

This study compares long-term outcomes of pharmacological interventions and conversion surgeries for managing recurrent weight gain after sleeve gastrectomy (SG). It highlights the increasing role of obesity management medications (OMMs) as a potential first-line treatment before considering surgical options.

Background

Recurrent weight gain after sleeve gastrectomy is a significant challenge, affecting 20-35% of patients. This issue necessitates effective management strategies to optimize weight control and minimize the need for more invasive procedures. Understanding the comparative effectiveness of OMMs and conversion surgeries is crucial for improving patient outcomes.

Data Highlights

This study is based on a retrospective analysis of a patient registry from a tertiary university hospital, focusing on patients with recurrent weight gain after SG.

Key Findings

• Recurrent weight gain after SG occurs in 20-35% of patients, often leading to conversion surgeries.
• Conversion procedures, such as Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB), are technically demanding and carry higher risks.
• Obesity management medications (OMMs), particularly GLP-1 receptor agonists, have shown superior efficacy compared to earlier agents.
• Current expert consensus supports a stepped-care approach, recommending OMM therapy before considering conversion surgery.
• Limited data exists on the long-term outcomes of OMM therapy compared to conversion surgery following SG.

Clinical Implications

Healthcare providers should consider a multimodal approach for patients experiencing recurrent weight gain after SG, prioritizing OMMs as a first-line treatment. This strategy may help delay or prevent the need for more invasive surgical interventions.

Conclusion

The findings underscore the importance of evaluating both pharmacological and surgical options for managing recurrent weight gain after sleeve gastrectomy, promoting a patient-centered approach to obesity management.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Author(s)/Org, Source, Year -- Title
6. Updates in Surgery — Omentopexy after laparoscopic sleeve gastrectomy in children and adolescents: is it effective in reducing post-operative complications?
7. IFSO global consensus recommendations for optimizing outcomes after sleeve gastrectomy
8. Liraglutide and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery
9. Postoperative outcomes following revision or conversion surgery after primary sleeve gastrectomy: an analysis of the MBSAQIP database - PubMed